Initial phase 1b/2 study results of purinostat mesylate (PM) in combination with pomalidomide (POM) and low dexamethasone (DEX) in patients with RRMM. This is an ASCO Meeting Abstract from the 2026 ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

We're long used to seeing dogs do tricks with balls in movies and home videos, but they tend to be real dogs, not robots. So it may have been a tad off-putting when one person visiting the AT&T ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

Democrats believe they now have “multiple paths” to flipping the Senate this year, touting strong recruits in some deep red states and a message focused on costs and health care. And, for the first ...

Although we suspect few Terrain AT4 owners will ultimately venture off-road in any real capacity, the AT4 trim is arguably the variant in which all Terrains will derive their credibility. While its ...